91PDRaman microscopy for the identification of an aggressive variant of prostate cancer, intraductal carcinoma of the prostate
ConclusionsAs clinically available biomarkers of IDC have reported sensitivities/specificities of ∼80%, we here identified IDC with accuracies ≥85%. Since our classification model was trained on a cohort and independently tested on the other two, these are likely to be close to real life experience making clinical implementation a realistic outcome.Legal entity responsible for the studyThe authors.FundingCentre de Recherche du Centre Hospitalier de l ’Université de Montréal (CRCHUM, continuum program) IVADO, Institut de valorisation des données.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Carcinoma | Learning | Legislation | Pathology | Prostate Cancer | Prostatectomy | Training | Universities & Medical Training | USA Health